The proapoptotic BH3-only protein BAD transduces cell death signals independently of its interaction with Bcl-2

Cell Death and Differentiation

Volumn 9, Issue 11, 2002, Pages 1240-1247

  Adachi, M ^a   Imai, K ^a  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

Apoptosis; BAD; Bcl 2 family; BH3 domain; Phosphorylation

Indexed keywords

ASPARTIC ACID; GLYCINE; MUTANT PROTEIN; PROTEIN BAD; PROTEIN BCL 2; PROTEIN BCL XL; BAD PROTEIN, HUMAN; BCL2L1 PROTEIN, HUMAN; CARRIER PROTEIN; PROTEIN BCL X;

AMINO ACID SUBSTITUTION; ANIMAL CELL; APOPTOSIS; ARTICLE; BIOASSAY; CELL DEATH; CELL STRAIN COS7; CONFOCAL MICROSCOPY; CONTROLLED STUDY; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INHIBITION KINETICS; MITOCHONDRIAL MEMBRANE; NONHUMAN; PRECIPITATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; ANIMAL; CELL STRAIN COS1; GENETICS; METABOLISM; MITOCHONDRION; MUTATION; PHYSIOLOGY;

AMINO ACID SUBSTITUTION; ANIMALS; APOPTOSIS; BCL-ASSOCIATED DEATH PROTEIN; BCL-X PROTEIN; CARRIER PROTEINS; COS CELLS; HUMANS; MITOCHONDRIA; MUTATION; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION;

EID: 0036848317     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4401097     Document Type: Article

References (33)

1. Adams JM and Cory S (1998) The Bcl-2 protein family: arbiters of cell survival. Science 281: 1322-1326
2. Gross A, McDonnell JM and Korsmeyer SJ (1999) BCL-2 family members and the mitochondria in apoptosis. Genes Dev. 13: 1899-1911
3. Kelekar A and Thompson CB (1998) Bcl-2-family proteins: the role of the BH3 domain in apoptosis. Trends Cell Biol. 8: 267-271
4. Puthalakath H, Villunger A, O'Reilly LA, Beaumont JG, Coultas L, Cheney RE, Huang DCS and Strasser A (2001) Bmf: A proapoptotic BH3-only protein regulated by interaction with the myosin V actin motor complex, activated by anoikis. Science 293: 1829-1832
5. Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, Yamashita T, Tokino T, Taniguchi T and Tanaka N (2000) Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 288: 1053-1058
6. Yang E, Zha J, Jockel J, Boise LH, Thompson CB and Korsmeyer SJ (1995) Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death. Cell 80: 285-291
7. Zha J, Harada H, Yang E, Jockel J and Korsmeyer SJ (1996) Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-XL. Cell 87: 619-628
8. Zha J, Harada H, Osipov K, Jockel J, Waksman G and Korsmeyer SJ (1997) BH3 domain of BAD is required for heterodimerization J. Biol. Chem. 272: 24101-24104
9. O'Connor L, Strasser A, O'Reilly LA, Hausmann G, Adam JM, Cory S and Huang DC (1998) Bim: a novel member of the Bcl-2 family that promotes apoptosis. EMBO J. 17: 384-395
10. Li H, Zhu H, Xu CJ and Yuan J (1998) Cleavage of BID bycaspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94: 491-501
11. Luo X, Budilhardjo I, Zou H, Slaughter C and Wang X (1998) Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94: 481-490
12. Wei MC, Lindsten T, Mootha VK, Weiler S, Gross A, Ashiya M, Thompson CB and Korsmeyer SJ (2000) tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c. Genes Dev. 14: 2060-2071
13. Zong W-X, Lindsten T, Ross AJ, MacGregor GR and Thompson CB (2001) BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak. Genes Dev. 15: 1481-1486
14. Hirai I and Wang H-G (2001) Survival-factor-induced phosphorylation of Bad results in its dissociation from Bcl-x(L) but not Bcl-2. Biochem. J. 359: 345-352
15. Kitada S, Krajewska M, Zhang X, Scudiero D, Zapata JM, Wang HG, Shabaik A, Tudor G, Krajewski S, Myers TG, Johnson GS, Sausville EA and Reed JC (1998) Expression and location of pro-apoptotic Bcl-2 family protein BAD in normal human tissues and tumor cell lines. Am. J. Pathol. 152: 51-61
16. Nechushtan A, Smith CL, Lamensdorf I, Yoon S-H and Youle RJ (2001) Bax and Bak coalesce into novel mitochondria-associated clusters during apoptosis. J. Cell Biol. 153: 1265-1276
17. Kelekar A, Chang BS, Harlan JE, Fesik SW and Thompson CB (1997) Bad is a BH3 domain-containing protein that forms an inactivating dimer with Bcl-XL. Mol. Cell. Biol. 17: 7040-7046
18. Wang HG, Pathan N, Ethell IM, Krajewski S, Yamaguchi Y, Shibasaki F, McKeon F, Bobo T, Franke TF and Reed JC (1999) Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD. Science 284: 339-343
19. Schimmer AD, Hedley DW, Pham NA, Chow S and Minden MD. (2001) BAD induces apoptosis in cells over-expressing Bcl-2 or Bcl-xL without loss of mitochondrial membrane potential. Leuk Lymphoma 42: 429-443
20. Dramsi S, Scheid MP, Maiti A, Hojabrpour P, Chen X, Schubert K, Goodlett DR, Aebersold R and Duronio V. (2002) Identification of a Novel Phosphorylation Site, Ser-170, as a Regulator of Bad Pro-apoptotic Activity. J. Biol. Chem. 277: 6399-6405
21. Chou JJ, Li H, Salvesen GS, Yuan J and Wagner G (1999) Solution structure of BID, an intracellular amplifier of apoptotic signaling. Cell 96: 615-624
22. McDonnell JM, Fushman D, Milliman CL, Korsmeyer SJ and Cowburn D (1999) Solution structure of the proapoptotic molecule BID: a structural basis for apoptotic agonists and antagonists. Cell 96: 625-634
23. Petros AM, Medek A, Nettesheim DG, Kim DH, Yoon HS, Swift K, Matayochi ED, Oltersdorf T and Fesik SW (2001) Solution structure of the antiapoptotic protein bcl-2. Proc. Natl. Acad. Sci. USA 98: 3012-3017
24. Wang K, Gross A, Waksman G and Korsmeyer SJ (1998) Mutagenesis of the BH3 domain of BAX identifies residues critical for dimerization and killing. Mol. Cell Biol. 18: 6083-6089
25. Wang K, Yin X-M, Chao DT, Milliman CL and Korsmeyer SJ (1996) BID: a novel BH3 domain-only death agonist. Genes Dev. 10: 2859-2869
26. Ottilie S, Diaz JL, Horne W, Chang J, Wang Y, Wilson G, Chang S, Weeks S, Fritz LC and Oltersdorf T (1997) Structural and functional complementation of an inactive Bcl-2 mutant by Bax truncation. J. Biol. Chem. 272: 30866-30872
27. Wei MC, Lindsten T, Mootha VK, Weiler S, Gross A, Ashiya M, Thompson CB and Korsmeyer SJ (2000) tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c. Genes Dev. 14: 2060-2071
28. Wei MC, Zong W-X, Cheng EH-Y, Lindsten T, Panoutsakopoulou V, Ross AJ, Roth KA, MacGregor GR, Thompson CB and Korsmeyer SJ (2001) Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292: 727-730
29. Condorelli F, Salomoni P, Cotteret S, Cesi V, Srinivasula SM, Alnemri ES and Calabretta B (2001) Caspase cleavage enhances the apoptosis-inducing effects of BAD. Mol. Cell Biol. 21: 3025-3036
30. Vallette F, Mege E, Reiss A and Milton A (1989) Construction of mutant and chimeric genes using the polymerase chain reaction. Nucleic Acid Res. 17: 723-733
31. Takaoka A, Adachi M, Okuda H, Sato S, Yawata A, Hinoda Y, Takayama S, Reed JC and Imai K (1997) Anti-cell death activity promotes pulmonary metastasis of melanoma cells. Oncogene 14: 2971-2977
32. Shimizu S, Eguchi Y, Kosaka H, Kamilke W, Matsuda H and Tsujimoto Y (1995) Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-xL. Nature 374: 811-813
33. Yawata A, Adachi M, Okuda H, Naishiro Y, Takamura T, Hareyama M, Takayama S, Reed JC and Imai K (1998) Prolonged cell survival enhances peritoneal dissemination of gastric cancer cells. Oncogene 16: 2681-2686